N. Wasala

发表

The evolution of heart gene delivery vectors

D. Duan, N. Wasala, Jin-Hong Shin, 2011, The journal of gene medicine.

Duchenne muscular dystrophy animal models for high-throughput drug discovery and precision medicine

Shi-jie Chen, D. Duan, N. Wasala, 2020, Expert opinion on drug discovery.

Questions Answered and Unanswered by the First CRISPR Editing Study in a Canine Model of Duchenne Muscular Dystrophy.

Chady H Hakim, Shi-jie Chen, D. Duan, 2019, Human gene therapy.

Treating Duchenne Cardiomyopathy in the Mouse Model by Gene Repair

C. Gersbach, D. Duan, N. Wasala, 2017 .

100-fold but not 50-fold dystrophin overexpression aggravates electrocardiographic defects in the mdx model of Duchenne muscular dystrophy

D. Duan, N. Wasala, Y. Yue, 2016, Molecular therapy. Methods & clinical development.

AAV micro-dystrophin gene therapy alleviates stress-induced cardiac death but not myocardial fibrosis in >21-m-old mdx mice, an end-stage model of Duchenne muscular dystrophy cardiomyopathy.

D. Duan, N. Wasala, Jin-Hong Shin, 2012, Journal of molecular and cellular cardiology.

Exclusive skeletal muscle correction does not modulate dystrophic heart disease in the aged mdx model of Duchenne cardiomyopathy.

D. Duan, N. Wasala, Y. Yue, 2013, Human molecular genetics.

Partial restoration of cardiac function with ΔPDZ nNOS in aged mdx model of Duchenne cardiomyopathy.

D. Duan, N. Wasala, Y. Yue, 2014, Human molecular genetics.

Cardiac-Specific Expression of ΔH2-R15 Mini-Dystrophin Normalized All Electrocardiogram Abnormalities and the End-Diastolic Volume in a 23-Month-Old Mouse Model of Duchenne Dilated Cardiomyopathy.

D. Duan, N. Wasala, Jin-Hong Shin, 2018, Human gene therapy.

Proteomic analysis identifies key differences in the cardiac interactomes of dystrophin and micro-dystrophin

D. Duan, N. Wasala, Y. Yue, 2021, Human molecular genetics.

The gRNA vector level determines the outcome of systemic AAV CRISPR therapy for Duchenne muscular dystrophy.

Chady H Hakim, Shi-jie Chen, D. Duan, 2022, Human gene therapy.

Uniform low-level dystrophin expression in the heart partially preserved cardiac function in an aged mouse model of Duchenne cardiomyopathy.

D. Duan, N. Wasala, Y. Yue, 2017, Journal of molecular and cellular cardiology.

The FVB Background Does Not Dramatically Alter the Dystrophic Phenotype of Mdx Mice

Chady H Hakim, D. Duan, N. Wasala, 2015, PLoS currents.

Genomic removal of a therapeutic mini-dystrophin gene from adult mice elicits a Duchenne muscular dystrophy-like phenotype.

D. Duan, N. Wasala, Jin-Hong Shin, 2016, Human molecular genetics.

Identification and expression of macrophage migration inhibitory factor in Sarcoptes scabiei.

N. Wasala, N. Côté, L. Arlian, 2013, Experimental parasitology.

Single SERCA2a Therapy Ameliorated Dilated Cardiomyopathy for 18 Months in a Mouse Model of Duchenne Muscular Dystrophy.

R. Hajjar, D. Duan, N. Wasala, 2020, Molecular therapy : the journal of the American Society of Gene Therapy.

AAV9 Edits Muscle Stem Cells in Normal and Dystrophic Adult Mice.

Chady H Hakim, Shi-jie Chen, C. Gersbach, 2019, Molecular therapy : the journal of the American Society of Gene Therapy.

A Five-Repeat Micro-Dystrophin Gene Ameliorated Dystrophic Phenotype in the Severe DBA/2J-mdx Model of Duchenne Muscular Dystrophy

Chady H Hakim, D. Duan, Xiufang Pan, 2017, Molecular therapy. Methods & clinical development.

Cas9-specific immune responses compromise local and systemic AAV CRISPR therapy in multiple dystrophic canine models

Chady H Hakim, D. Grimm, Shi-jie Chen, 2021, Nature Communications.

AAV CRISPR editing rescues cardiac and muscle function for 18 months in dystrophic mice.

Keqing Zhang, Dongsheng Duan, Charles A. Gersbach, 2018, JCI insight.

Evaluation of Muscle Function of the Extensor Digitorum Longus Muscle Ex vivo and Tibialis Anterior Muscle In situ in Mice

Dongsheng Duan, D. Duan, N. Wasala, 2013, Journal of visualized experiments : JoVE.

The implication of hinge 1 and hinge 4 in micro-dystrophin gene therapy for Duchenne muscular dystrophy.

D. Duan, N. Wasala, Y. Yue, 2022, Human gene therapy.

Macrophage migration inhibitory factor expression and protein localization in Amblyomma americanum (Ixodidae)

N. Wasala, C. J. Bowen, D. Jaworski, 2010, Experimental and Applied Acarology.

Amblyomma americanum (L): tick macrophage migration inhibitory factor peptide immunization lengthens lone star tick feeding intervals in vivo.

N. Wasala, C. J. Bowen, D. Jaworski, 2009, Experimental parasitology.

A white-tailed deer/lone star tick model for studying transmission of Ehrlichia chaffeensis.

N. Wasala, C. J. Bowen, D. Jaworski, 2013, Vector borne and zoonotic diseases.

Dermacentor variabilis: characterization and modeling of macrophage migration inhibitory factor with phylogenetic comparisons to other ticks, insects and parasitic nematodes.

N. Wasala, D. Jaworski, 2012, Experimental parasitology.

Pyrosequencing and characterization of immune response genes from the American dog tick, Dermacentor variabilis (L.)

N. Wasala, Haobo Jiang, K. Kocan, 2010, Insect molecular biology.

Life-long outcomes of systemic AAV micro-dystrophin gene therapy in a murine Duchenne muscular dystrophy model.

D. Duan, N. Wasala, Jin-Hong Shin, 2022, Human gene therapy.

AAV micro-dystrophin gene therapy alleviates stress-induced cardiac death but not myocardial fibrosis in >21-m-old mdx mice, an end-stage model of Duchenne muscular dystrophy cardiomyopathy.

D. Duan, N. Wasala, Jin-Hong Shin, 2012, Journal of molecular and cellular cardiology.

499. Intravenous Delivery of a Novel Micro-Dystrophin Vector Prevented Muscle Deterioration in Young Adult Canine Duchenne Muscular Dystrophy Dogs

Gregory J Jenkins, D. Duan, Xiufang Pan, 2016 .